Skip to main content
Log in

Nutrient optimization for high density biological production applications

  • Published:
Cytotechnology Aims and scope Submit manuscript

Conclusion

At the 1989 annual meeting of the U.S. Tissue Culture Associations, Ricahrd am, a leading investigator in the serum-free nutrient requirements of cultured cells, commented on the process of medium development. He noted that a survey of major media manufacturers revealed that, among the top selling mammalian cell culture media formulations, most were nearly thirty years old.

This commentary is noteworthy considering the tremendous changes in cell culture understanding and derived applications which have emerged over these three decades. Fastidious cell types relatively unknown to investigators of the 1950s and 1960s are now being cultivated in defined, serum-free environments. Culture environments range from limiting dilution clonal recoveries to maintenance cultures approaching tissue densities. While research applications continue to predominate, applications of cell culture have expanded to the engineered production of biopharmaceuticals, to replacement of animal models for toxicology testing, and to the preservation, activation and expansion of human cells, tissues and organs.

It is likely that future nutrient medium development will be predicated upon the design of a minimal number of defined formulations of relatively generic utility to a broad class of cell types. Analytical techniques derived from those described herein will be exploited in the user laboratory and in collaboration with the supplier to optimize the nutrient composition for the desired biological response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barnes D (1987) Serum-free animal cell culture. BioTechniques 5: 534–542.

    Google Scholar 

  • Barnes DW, Sirbasku DA and Sato GH (1984) Cell culture methods for molecular and cell biology. Vols. 1–4. Liss, New York.

    Google Scholar 

  • Beckner SK, Maluish AE and Longo DL (1987) Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors. Canc. Res. 47: 5504–5508.

    Google Scholar 

  • Bodziak ML, Grefrath PL, Price PJ and Jayme DW (1985) Mammalian cell proliferation in low serum medium. J. Cell. Biology 105: 162a.

  • Boone CW, Mantel N, Caruso TD, Kazam E and Stevenson RE (1972) Quality control studies on fetal bovine serum used in tissue culture. In Vitro 7: 174–189.

    Google Scholar 

  • Bottenstein J, Hayashi I, Hutchings S, Masui H, Mather J, McClure DB, Ohasa S, Rizzino A, Sato G, Serrero G, Wolfe R and Wu R (1979) The growth of cells in serum-free hormone-supplemented media. Meth. Enzymol. 58: 94–109.

    Google Scholar 

  • Brown BL (1987) Reducing costs upfront: two methods for adapting hybridoma cells to an inexpensive, chemically-defined serum-free medium. In: Seaver S (ed.) Commercial Production of Monoclonal Antibodies, Marcel Dekker, New York, pp. 35–48.

    Google Scholar 

  • Clark JM and Hirtenstein MD (1981) Optimizing culture conditions for the production of animal cells in microcarrier culture. Ann. NY Acad. Sci. USA 369: 33–46.

    Google Scholar 

  • Cohn EJ, Strong LE, Hughes WLJr, Mulford DJ, Ashworth JN, Melin M and Taylor HL (1946) Preparation and properties of serum and plasma proteins: a system for the separation into fractions of protein and lipoprotein components of biological tissues and fluids. J. Amer. Chem. Soc. 68: 459–475.

    Google Scholar 

  • Danner D and Jayme DW (1987) Virus testing of fetal bovine serum. In Vitro 23: 19a.

  • Eagle H (1955) Nutrition needs of mammalian cells in culture. Science 122: 501–504.

    Google Scholar 

  • Epstein DA, Weppner DJ, Fike RM, Jayme DW and Darfler FJ (1988) A serum-free medium for lymphokine-activated killer (LAK) cells and other lymphoid cells. Proceedings of 19th International Leukocyte Culture Conference, Banff.

  • Epstein DA, Weppner DJ, Jayme DW and Darfler FJ (1987) Development of a serum-free medium for adoptive immunotherapy using lymphokine-activated killer (LAK) cells. J. Cell. Biol. 105: 47a.

  • Epstein DA, Weppner DJ, Jayme DW, Boldt DH and Darfler FJ (1988) AIM-V, a serum-free medium for adoptive immunotherapy using lymphokine activated killer (LAK) cells. Proceedings of UCLA Symposium on Mechanisms of Action and Therapeutic Application of Biologicals in Cancer and Immune Deficiency, Keystone.

  • Evege EK, Nash CR, Bodziak ML and Jayme DW (1985) Alternative serum substitutes for fetal bovine serum. J. Cell. Biology 101: 489a.

  • Familletti PC and Fredericks JE (1988) Techniques for mammalian cell immobilization. Bio/Technology 6: 41–44.

    Google Scholar 

  • Feder J and Tolbert WR (1983) The large scale cultivation of mammalian cells. Scientific American 248: 36–43.

    Google Scholar 

  • Fike RM, Pfohl JL, Epstein DA and Jayme DW (1988) Protein-free hybridoma cultivation. Proceedings of Biotech USA '88, San Francisco.

  • Fike RM, Pfohl JL, Epstein DA and Jayme DW (1989) Monoclonal antibody production in protein-free hybridoma medium. Proceedings of the ASM Conference on Biotechnology, Orlando.

  • Fouron Y (1988) Protein production from animal cells: the role of contract manufacturers. BioPharm. June: 34–37.

  • Freshney RI (1987) Culture of animal cells: a manual of basic technique (2nd edition). Liss, New York.

    Google Scholar 

  • Glacken MW (1988) Catabolic control of mammalian cell culture. Bio/Technology 6: 1041–1050.

    Google Scholar 

  • Glacken MW, Fleischaker RJ and Sinskey AJ (1986) Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotech. Bioeng. 28: 1376–1389.

    Google Scholar 

  • Glassy MC, Tharakan JP and Chau PC (1988) Serum-free media in hybridoma culture and monoclonal antibody production. Biotech. Bioeng. 32: 1015–1028.

    Google Scholar 

  • Goldberg AM and Frazier JM (1989) Alternatives to animals in toxicity testing. Scientific American 261: 24–30.

    Google Scholar 

  • Gravell M (1985) Chemically defined tissue culture media: history, advantages of use and prospects for improvement. Laboratory Dynamics 1: 36–43.

    Google Scholar 

  • Grimm EA (1986) Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality. Biochim. Biophys. Acta 865: 267–279.

    Google Scholar 

  • Ham RG and McKeehan WL (1979) Media and growth requirements. Methods in Enzymology 58: 44–93.

    Google Scholar 

  • Helinski EM, Bielat KL, Ovak GM and Pauly JL (1988) Long-term cultivation of functional human macrophages in teflon dishes with serum-free medium. J. Leuk. Biol. 44: 111–121.

    Google Scholar 

  • Hink WF and Bezanson DR (1985) Invertebrate cell culture media and cell lines. Techniques in the Life Sciences C 111: 1–30.

    Google Scholar 

  • Hink WF (1979) Cell lines from invertebrates. Methods in Enzymology 58: 450–466.

    Google Scholar 

  • Hopkinson J (1985) Hollow fiber cell culture systems for economical cell-product manufacturing. Bio/Technology 3: 225–230.

    Google Scholar 

  • Hu W-S and Sinskey AJ (1988) The Engineering Foundation Conference of Cell Culture Engineering. National Science Foundation, Washington DC.

    Google Scholar 

  • Imamura T, Crespi CL, Thilly WG and Brunengraber H (1982) Fructose as a carbohydrate source yields stable pH and redox parameters in microcarrier cell culture. Anal. Biochem. 124: 353–358.

    Google Scholar 

  • Iscove N and Melchers F (1978) Complete replacement of serum by albumin, transferrin and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes. J. Exp. Med. 147: 922–933.

    Google Scholar 

  • Jadus MR, Thurmond GB, Mrowca-Bastin A and Yanelli J (1988) Generation of human lymphokine-activated killer cells in various serum-free media. J. Immunol. Meth. 109: 169–174.

    Google Scholar 

  • Jayme DW (1990) Alternatives to fetal bovine serum for mammalian cell culture. Focus 12: 3–8.

    Google Scholar 

  • Jayme DW and Blackman KE (1985) Culture media for propagation of mammalian cells, viruses, and other biologicals. In: Mizrahi A and van Wezel AL (eds.) Advances in Biotechnological Processes. Vol. 5, Liss, New York, pp. 1–30.

    Google Scholar 

  • Jayme DW, Epstein DA and Conrad DR (1988) Fetal bovine serum alternatives. Nature 334: 547–548.

    Google Scholar 

  • Katinger HWD and Bliem R (1983) Production of enzymes and hormones by mammalian cell culture. In: Mizrahi A and van Wezel AL (eds.) Advances in Biotechnological Processes. Vol. 2, Liss, New York, pp. 61–95.

    Google Scholar 

  • Lafreniere R and Rosenberg SA (1985) Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J. Immunol. 135: 4273–4280.

    Google Scholar 

  • Lambert KJ and Birch JR (1985) Cell growth media. In: Spier RE and Griffiths JB (eds.) Animal Cell Biotechnology. Vol. 1, Academic, New York, pp. 85–122.

    Google Scholar 

  • Larrick JW and Buck DW (1984) Practical aspects of human monoclonal antibody production. BioTechniques Jan/Feb: 6–14.

  • Luan YT, Mutharasan R and Magee WE (1987) Effect of various glucose/glutamine ratios on hybridoma growth, viability and monoclonal antibody formation. Biotech. Lett. 9: 535–538.

    Google Scholar 

  • Luckow VA and Summers MD (1988) Trends in the development of baculovirus expression vectors. Bio/Technology 6: 47–55.

    Google Scholar 

  • MacMichael GJ (1988) The use of perfusion in mammalian cell culture. Amer. Biotech. Lab. April: 34–42.

  • Marino MH (1989) Expression systems for heterologous protein production. BioPharm. Jul/Aug: 18–33.

  • Martinez EC, Cady DJ, Grefrath PL and Jayme DW (1985) Biological profiling of fetal bovine serum. In Vitro 21: 30a.

  • Mather JP (1984) Mammalian Cell Culture: The Use of Serum-free, Hormone-supplemented Media, Plenum, New York.

    Google Scholar 

  • McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H and Sato GH (1990) Frontiers in mammalian cell culture. In Vitro Cell. Dev. Biol. 26: 9–23.

    Google Scholar 

  • McLimans WF (1979) Mass culture of mammalian cells. Methods in Enzymology 58: 194–211.

    Google Scholar 

  • Moellering BJ, Tedesco JL, Townsend RR, Hardy MR, Scott RW and Prior CP (1990) Electrophoretic differences in a MAb expressed in three media. BioPharm. Feb: 30–38.

  • Moore GE, Gerner RE and Franklin HA (1967) Culture of normal human lymphocytes. J. Amer. Med. Assoc. 199: 519–524.

    Google Scholar 

  • Morton HC (1970) A survey of commercially available tissue culture media. In Vitro 6: 89–108.

    Google Scholar 

  • Moya ML, Quinn A, Melincoff G and Hevey RC (1984) Practical aspects of monoclonal antibody production. Med. Dev. Diag. Ind. 6: 45–48,99.

    Google Scholar 

  • Murakami H (1989) Serum-free media used for cultivation of hybridomas. In: Mizrahi A (ed.) Monoclonal Antibodies: Production and Application, Liss, New York, pp. 107–141.

    Google Scholar 

  • Muhrhammer DW and Goochee CF (1988) Scale-up of insect cell cultures: protective effect of pluronic F-68. Bio/Technology 12: 1411–1415.

    Google Scholar 

  • Muul LM, Nason-Burchenal K, Hyatt C, Schwarz S, Slavin D, Director EP and Rosenberg SA (1987) Studies of serum-free culture medium in the generation of lymphokine-activated killer cells. J. Immunol. Meth. 105: 183–192.

    Google Scholar 

  • Ogden G and Foldi P (1987) Amino acid analysis: an overview of current methods. LC-GC 5: 28–40.

    Google Scholar 

  • Patterson MK (1979) Measurement of growth and viability of cells in culture. Methods in Enzymology 58: 141–152.

    Google Scholar 

  • Payne CC (1989) Insect pest management concepts: the role of biological control. In: Roberts DW and Granados RR (eds.) Biotechnology, Biological Pesticides and Novel Plant-Pest Resistance for Insect Pest Management, Cornell University Press, Ithaca, pp. 1–7.

    Google Scholar 

  • Peterson WD, Tribby I, Halat M and Jayme DW (1990) Fetal bovine serum standardization subcommittee report. National Committee for Clinical Laboratory Standards (in press).

  • Prior CP, Doyle KR, Duffy SA, Hope JA, Moellering BJ, Prior GM, Scott RW and Tolbert WR (1989) The recovery of highly purified biopharmaceuticals from perfusion cell culture bioreactors. J. Parent. Sci. Tech. 43: 15–23.

    Google Scholar 

  • Reuveny S (1983) Microcarriers for culturing mammalian cells and their applications. In: Mizrahi A and van Wezel AL (eds.) Advances in Biotechnological Processes. Vol. 2, Liss, New York, pp. 1–32.

    Google Scholar 

  • Reuveny S, Velez D, Macmillan JD and Miller L (1986) Factors affecting cell growth and monoclonal antibody production in stirred reactors. J. Immunol. Meth. 86: 53–59.

    Google Scholar 

  • Rosa MD (1989) Serum substitutes: Is there a solution? BioPharm. March 16–17.

  • Rosenberg SA, Spiess P and Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318–1321.

    Google Scholar 

  • Sato GH (1975) The role of serum in cell culture. In: Litwak G (ed.) Biochemical Actions of Hormones. Vol. 3, Academic, New York, pp. 391–396.

    Google Scholar 

  • Sato GH, Pardee AB and Sirbasku DA (1982) Growth of cells in hormonally defined media. Books A and B. Cold Spring Harbor, New York.

  • Schlom J (1988) Monoclonal antibodies in cancer therapy: the present and the future. BioPharm Sept: 44–48.

  • Shacter E (1989) Serum-free media for bulk culture of hybridoma cells and the preparation of monoclonal antibodies. Trends Biotech., pp. 248–253.

  • Spector AA (1972) Fatty acid, glyceride, and phospholipid metabolism. In: Rothblat GH and Cristofalo VJ (eds.) Growth, Nutrition, and Metabolism of Cells in Culture. Vol. II, Academic, New York, pp. 257–298.

    Google Scholar 

  • Spier RE (1983) Production of veterinary vaccines. In: Mizrahi A and van Wezel AL (eds.) Advances in Biotechnological Processes. Vol. 2, Liss, New York, pp. 33–59.

    Google Scholar 

  • Summers MD and Smith GE (1987) A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station, College Station.

    Google Scholar 

  • Taub M (1985) Tissue Culture of Epithelial Cells. Plenum, New York.

    Google Scholar 

  • Vialard J, Lalumiere M, Vernet T, Briedis D, Alkhatib G, Henning D, Levin D and Richardson C (1990) Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the β-galactosidase gene. J. Virol. 64: 37–50.

    Google Scholar 

  • Waymouth C (1972) Construction of tissue culture media. In: Rothblat GH and Cristofalo VJ (eds.) Growth, Nutrition, and Metabolism of Cells in Culture. Academic, New York.

    Google Scholar 

  • Weiss SA, Belisle BW, DeGiovanni A, Godwin G, Kohler J and Summers MD (1989) Insect cells as substrates for biologicals. Develop. Biol. Standard. 70: 271–279.

    Google Scholar 

  • Weiss SA, Lester TL, Kalter SS and Heberling RL (1980) Chemically defined serum free media for the cultivation of primary cells and their susceptibility to viruses. In Vitro 16: 616–628.

    Google Scholar 

  • Weiss SA and Vaughn JL (1986) Cell culture methods for large-scale propagation of baculoviruses. In: Granados RR and Federici BA (eds.) The Biology of Baculoviruses. Vol. 2, CRC Press, pp. 63–87.

  • Zielke HR, Ozand PT, Tildon JT, Sevdalian DA and Cornblath M (1978) Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts. J. Cell. Physiol. 95: 41–48.

    Google Scholar 

  • Zielke HR, Zielke CL and Ozand PT (1984) Glutamine: a major energy source for cultured mammalian cells. Fed. Proc. 43: 121–125.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jayme, D.W. Nutrient optimization for high density biological production applications. Cytotechnology 5, 15–30 (1991). https://doi.org/10.1007/BF00365531

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00365531

Key words

Navigation